Naphthalenes

Apexbio Technology LLC BI-2865-1MG

BI-2865 (CAS No 2937327-93-8) is a synthetic small molecule researched in the field of oncology for its potential as a therapeutic agent Originating from advanced medicinal chemistry efforts it acts by targeting specific protein pathways involved in cell proliferation and survival particularly inhibiting kinases that play a crucial role in tumor growth The compound exhibits potent in vitro activity generally within the nanomolar to low micromolar range making it a promising candidate for further investigation BI-2865 is commonly applied in various cell models and has shown efficacy in preclinical animal studies contributing to its evaluation in drug screening processes Its experimental concentrations typically depend on the specific research design allowing for tailored investigations into its therapeutic potential and mechanism of action

Apexbio Technology LLC BI-2865-10MG

BI-2865 (CAS No 2937327-93-8) is a synthetic small molecule researched in the field of oncology for its potential as a therapeutic agent Originating from advanced medicinal chemistry efforts it acts by targeting specific protein pathways involved in cell proliferation and survival particularly inhibiting kinases that play a crucial role in tumor growth The compound exhibits potent in vitro activity generally within the nanomolar to low micromolar range making it a promising candidate for further investigation BI-2865 is commonly applied in various cell models and has shown efficacy in preclinical animal studies contributing to its evaluation in drug screening processes Its experimental concentrations typically depend on the specific research design allowing for tailored investigations into its therapeutic potential and mechanism of action

Apexbio Technology LLC BI-2865-5MG

BI-2865 (CAS No 2937327-93-8) is a synthetic small molecule researched in the field of oncology for its potential as a therapeutic agent Originating from advanced medicinal chemistry efforts it acts by targeting specific protein pathways involved in cell proliferation and survival particularly inhibiting kinases that play a crucial role in tumor growth The compound exhibits potent in vitro activity generally within the nanomolar to low micromolar range making it a promising candidate for further investigation BI-2865 is commonly applied in various cell models and has shown efficacy in preclinical animal studies contributing to its evaluation in drug screening processes Its experimental concentrations typically depend on the specific research design allowing for tailored investigations into its therapeutic potential and mechanism of action